Back to Agenda
[DIAmond Session 1] Vision of Future Drug Development in Utilizing Next-Generation Medical ICT
Session Chair(s)
Yasuhiro Fujiwara, MD, PhD
Chief Executive
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Yoshihiko Ono, RPh
Head of Regulatory Affairs
MSD K.K., Japan
Recently, under the Healthcare Policy, discussions are ongoing for Next-Generation Medical ICT on aiming to build and to utilize digital infrastructure in the areas of medical, nursing care, and health care. In this session, we will hold a panel discussion to offer respective views from industrial, academic, and government perspectives on the future direction of Next-Generation Medical ICT, and vision of future Drug Development including utilization or potential impact of ICT on clinical studies or on review for drug approval.
Speaker(s)
Policy and its Aim of Next-Generation Medical Information and Communication Technology (ICT)
Kouji Fujimoto
Cabinet Secretariat, Japan
Deputy Director-General, Office of Health and Medical Policy
Vision of Future Drug Development in Utilizing Next-Generation Medical ICT
Kazuhiko Mori, PhD, MSc
Japan Pharmaceutical Manufacturers Association (JPMA), Japan
Senior Managing Director
Drug Development Utilized Next Generation ICT - PMDA’s Efforts -
Tatsuya Kondo, MD, PhD
SH Medical Excellence JAPAN, Japan
President
Tomohiro Sawa, MD, PhD
Teikyo University Hospital, Japan
Professor, Medical Information Systems Research Center
Have an account?